Viking Therapeut (VKTX)
$29.12
1.30 (4.46%)
VKTX Stock Quote Delayed 30 Minutes
3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024
Biotech stocks are some of the most exciting opportunities on the market. Find the right ones with catalysts, and you could make a fortune.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$28.32
Market Cap
3.10B
PE Ratio
-28.87
EPS
-1.0087
Volume (Avg. Vol.)
3.48M
Day's Range
$27.20 - $29.33
52-Week Range
$27.20 - $99.41
Dividend & Yield
N/A (N/A)
VKTX Stock Predictions, Articles, and Viking Therapeut News
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023
If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead.
Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich … or Broke.
These biotech companies are swinging for the fences. They may hit homers, they may strike out. But you'll definitely want to watch them.
Why Is Viking Therapeutics (VKTX) Stock Up 38% Today?
Viking Therapeutics (VKTX) stock is climbing higher on Tuesday after initiating a Phase 1 clinical trial of weight loss drug VK2735.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!
Why Is Viking Therapeutics (VKTX) Stock Up 67% Today?
Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company.
Should You Buy Viking Therapeutics After Gilead Drug Failure?
Viking Therapeutics stock got a boost from Gilead's failure earlier this week, but does that make VKTX stock a buy? Let's look.
Viking Therapeutics Stock Skyrockets on Promising Fatty Liver Treatment Results
Viking Therapeutics (VKTX) stock was entering orbit on Tuesday after releasing results from a recent study concerning fatty liver treatment.
